Sumitomo Mitsui Financial Group Inc. Has $1.05 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sumitomo Mitsui Financial Group Inc. trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,708 shares of the exchange traded fund’s stock after selling 577 shares during the period. Sumitomo Mitsui Financial Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,054,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $29,000. Kohmann Bosshard Financial Services LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Avior Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Lee Danner & Bass Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $38,000. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $43,000.

SPDR S&P Biotech ETF Stock Down 5.7 %

NYSEARCA:XBI opened at $73.66 on Monday. The firm has a market capitalization of $4.65 billion, a PE ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 12-month low of $70.16 and a 12-month high of $105.47. The firm has a 50-day moving average price of $88.13 and a 200 day moving average price of $93.12.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.